These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 776708)

  • 1. Treatment of idiopathic normogonadotropic oligoasthenospermia with synthetic luteinizing hormone-releasing hormone.
    Aparicio NJ; Schwarzstein L; Turner EA; Turner D; Mancini R; Schally AV
    Fertil Steril; 1976 May; 27(5):549-55. PubMed ID: 776708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-leucine-6-luteinizing hormone-releasing hormone ethylamide in the treatment of normogonadotropic oligoasthenospermia.
    Schwarzstein L; Aparicio NJ; Turner D; De Turner EA; Premoli F; Schally AV
    Fertil Steril; 1978 Mar; 29(3):332-5. PubMed ID: 346384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Tryptophan-6-luteinizing hormone-releasing hormone in the treatment of normogonadotropic oligoasthenozoospermia.
    Schwarzstein L; Aparicio NJ; Schally AV
    Int J Androl; 1982 Apr; 5(2):171-8. PubMed ID: 6213567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal response.
    Fauser BC; Rolland R; Dony JM; Corbey RS
    Andrologia; 1985; 17(2):143-9. PubMed ID: 3923865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients.
    Turner D; Turner EA; Aparicio NJ; Schwarzstein L; Coy DH; Schally AV
    Fertil Steril; 1976 May; 27(5):545-8. PubMed ID: 776707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia.
    Gross KM; Matsumoto AM; Berger RE; Bremner WJ
    Fertil Steril; 1986 Mar; 45(3):392-6. PubMed ID: 3081382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of synthetic luteinizing hormone-releasing hormone in treatment of oligospermic men: a preliminary report.
    Schwarzstein L; Aparicio NJ; Turner D; Calamera JC; Mancini R; Schally AV
    Fertil Steril; 1975 Apr; 26(4):331-6. PubMed ID: 1090456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-tryptophan-6-LH-RH-at los doses in the treatment of male subfertility.
    Levalle O; Tropea L; Aparicio N; Guitelman A; Mancini A; Schally AM; Schally V
    Andrologia; 1981; 13(3):207-11. PubMed ID: 6455942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolonged treatment with LH-RH of 6 men with oligoasthenozoospermia and normogonadotropic idiopathic azoospermia].
    Póvoa LC; Dos Santos RR; Schermann J; Comarú Schally AM; Schally AV
    Reproduccion; 1982; 6(3-4):151-8. PubMed ID: 6818054
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of timed ovulation with synthetic luteinizing hormone-releasing hormone in women undergoing insemination therapy. I. Effect of a single parenteral administration at midcycle.
    Grimes EM; Taymor ML; Thompson IE
    Fertil Steril; 1975 Mar; 26(3):277-82. PubMed ID: 1090455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clomiphene citrate on plasma levels of immunoreactive luteinizing hormone-releasing hormone, gonadotropin, and testosterone in normal subjects and in patients with idiopathic oligospermia.
    Masala A; Delitala G; Alagna S; Devilla L; Lotti G
    Fertil Steril; 1978 Apr; 29(4):424-7. PubMed ID: 348501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary and testicular response to hypothalamic LH-releasing hormone (LH-RH) in normal and oligospermic men.
    Schwarzstein L; Aparicio NJ; Turner D; de Turner EA; Premoli F; Rodriguez A; Schally AV
    Int J Fertil; 1976; (2):96-102. PubMed ID: 8391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of repeated injections of synthetic luteinizing hormone-releasing hormone on the response of plasma luteinizing hormone and follicle-stimulating hormone in young hypogonadotropic-hypogonadal patients.
    Dickerman Z; Prager-Lewin R; Laron Z
    Fertil Steril; 1976 Feb; 27(2):162-6. PubMed ID: 765164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunization against synthetic LHRH used therapeutically in prolonged administration].
    Mandelbaum J; Gayral MN; Piette F
    Nouv Presse Med; 1976 Oct; 5(34):2256. PubMed ID: 824620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of idiopathic hypogonadotropic hypogonadism in men with luteinizing hormone-releasing hormone: a comparison of treatment with daily injections and with the pulsatile infusion pump.
    Shargil AA
    Fertil Steril; 1987 Mar; 47(3):492-501. PubMed ID: 3549367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic luteinizing hormone-releasing hormone in impotent male diabetics.
    Levitt NS; Vinik AI; Sive AA; Klaff LJ; Phillips C
    S Afr Med J; 1980 Apr; 57(17):701-4. PubMed ID: 6996121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.